Collectively these results unveil a novel role for SRSF3 and hnRNPM in the regulation of DHX9 alternative splicing, which also impacts on Ewing sarcoma cell sensitivity to chemotherapeutic treatments. Here, HNRNPM is linked to Ewing sarcoma.